Reply to S. Goteti et al.
National Cancer Institute, Bethesda, MD.
Boris
B
Freidlin
Zhuoxin
Z
Sun
Robert
R
Gray
Edward L
EL
Korn
D014408:Biomarkers, Tumor / Q000032:analysis*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012107:Research Design
D014408:Biomarkers, Tumor